Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), modified with an added C-terminal sequence that improves stability. It is used in research as a tool for studying neuropeptide and neurotrophic signaling in controlled model systems, distinct from the melanocortin-agonist and growth-hormone families elsewhere in this library.
Design
The ACTH(4-10) core is coupled to a Pro-Gly-Pro extension that resists enzymatic breakdown, giving Semax substantially greater stability than the native fragment. This stabilization is what transforms an otherwise short-lived sequence into a practical research subject. The logic of such stabilizing modifications relates to general amino acid sequence principles.
What it is not
Although derived from ACTH, the fragment lacks the parent hormone's classic steroidogenic activity. This decoupling is important: Semax is studied for neuromodulatory readouts, not as an endocrine agent, which is why it occupies its own research niche.
Research interest
Semax is studied in neuroscience models around neurotrophic factors, including proposed influence on BDNF-related pathways, and cognition-related endpoints in animal preparations. Its proposed mechanism of action centers on these neurotrophic and neuromodulatory readouts. It is often mentioned alongside the related regulatory peptide Selank, which comes from a different parent sequence but shares a design philosophy.
Preclinical footprint
Its characterization in cultured neural cells and rodent models is summarized in its preclinical research article, framed strictly as controlled-model work.
Research context
As with all research peptides, characterized material matters — identity and purity determine whether results are interpretable. See third-party testing explained and how to read a COA for verifying that a given lot is what it claims to be.
Unresolved research questions
The initiating molecular target for Semax remains less clearly defined than the receptors of many classical peptide hormones. Current research questions include whether observed transcriptional changes follow direct peptide recognition, arise through peptide metabolites, or reflect indirect modulation of established neural pathways. The contribution of the Pro-Gly-Pro extension is another testable issue: beyond prolonging stability, it may alter distribution or interactions in a model. Experiments using sequence variants, receptor perturbations, time-resolved signaling, and orthogonal endpoint measurements can help distinguish these possibilities. Keeping these uncertainties explicit makes Semax useful as a hypothesis-generating neuropeptide tool without overstating the maturity of its mechanism.
Product page: Semax research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.